Patent · US Active

Treatment of synucleinopathies

US10213494B2 · kind B2 · utility

11Cited by
4References
8Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 24, 2016
Grant dateFeb 26, 2019
Priority date
Expiry dateJun 19, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y304/23005
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates generally to treating synucleinopathies in subjects that are not clinically diagnosed with a lysosomal storage disease, as well as associated methods of making medicaments and screening methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.